Gut-brain communication by distinct sensory neurons differently controls feeding and glucose metabolism
Tejaswi Kompala, Senior Director, Clinical Strategy, Teladoc Health and Robert Hsu, Director, Clinical Strategy, Teladoc Health The early stages of any new, clinically impactful drug put pressure on benefit leaders
S., Lo, W
You can read about Wegovy, compare Ozempic, explore compounded tirzepatide or oral semaglutide, or check your BMI to see where you stand before a consultation
On June 27, 2025, Innovent Biologics, Inc., a leading biopharmaceutical company focused on developing, manufacturing, and commercializing high-quality medicines for oncology, autoimmune, cardiovascular, and metabolic diseases, announced that China's National Medical Products Administration (NMPA) approved Mazdutide, the worlds first dual glucagon (GCG)/glucagon-like peptide-1 (GLP-1) receptor agonist, for chronic weight management in Chinese adults with overweight or obesity